We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: Impella
MedXY News
EnglishTag

Impella

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Refining Patient Selection for Microaxial Flow Pumps: The DanGer Shock-like Profile as a Survival Predictor in STEMI-CS
Cardiologycardiogenic shockImpella

Refining Patient Selection for Microaxial Flow Pumps: The DanGer Shock-like Profile as a Survival Predictor in STEMI-CS

By MedXY|Dec 31, 2025

This study validates the DanGer Shock trial criteria in a real-world registry, demonstrating that patients matching the trial’s profile have significantly better survival outcomes when treated with microaxial flow pumps compared to th

Beyond Survival: Unpacking the Hemodynamic and Metabolic Benefits of Microaxial Flow Pumps in STEMI-Related Cardiogenic Shock
Cardiologycardiogenic shockhemodynamics

Beyond Survival: Unpacking the Hemodynamic and Metabolic Benefits of Microaxial Flow Pumps in STEMI-Related Cardiogenic Shock

By MedXY|Dec 31, 2025

Recent substudies from the DanGer Shock trial demonstrate that microaxial flow pumps significantly improve hemodynamics, accelerate lactate clearance, and reduce vasopressor needs in STEMI-related cardiogenic shock, though sex-specific outc

Beyond the DanGer Shock Trial: Real-World Outcomes and Risk Stratification in Impella-Treated Patients
Cardiologycardiogenic shockImpella

Beyond the DanGer Shock Trial: Real-World Outcomes and Risk Stratification in Impella-Treated Patients

By MedXY|Dec 31, 2025

This article analyzes recent J-PVAD registry data, evaluating the real-world applicability of the DanGer shock trial criteria and prognostic factors for ECPELLA in acute myocardial infarction-related cardiogenic shock, emphasizing the neces

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities